The group's principle activity is to provide clinical and bioanalytical research services. The group provides services include cardiac safety studies, clinical pharmacology, dermatology, late stage development, central laboratory, and endocrinology and metabolic disorders. Customers served by the group include biotechnology, generic, and pharma industries. The group operates from United States.
